MPLT vs MS · $1.24B cap vs P/E 20, rev $7.76B
MapLight Therapeutics, Inc. Common Stock (MPLT) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
MPLT does not have a complete income-statement cache yet.
Latest reported MS revenue for 2014-12-31 was $7.76B. Net income was -$1.63B. Revenue was down 0.8% from 2013-12-31 to 2014-12-31. MS currently screens at market cap $344.27B and trailing P/E 19.8.
MPLT currently screens at market cap $1.24B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the MPLT and MS stock pages for the full models.
Not investment advice.